X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (76) 76
index medicus (67) 67
male (60) 60
female (56) 56
middle aged (52) 52
aged (51) 51
cardiac & cardiovascular systems (48) 48
clopidogrel (30) 30
abridged index medicus (26) 26
heart attacks (25) 25
percutaneous coronary intervention (25) 25
ticlopidine - analogs & derivatives (25) 25
prospective studies (22) 22
acute coronary syndromes (21) 21
treatment outcome (21) 21
cardiovascular (20) 20
risk factors (20) 20
aged, 80 and over (19) 19
hematology (19) 19
mortality (19) 19
peripheral vascular disease (19) 19
prognosis (19) 19
platelet aggregation inhibitors - administration & dosage (17) 17
platelet reactivity (16) 16
stents (16) 16
thrombosis (16) 16
ticlopidine - administration & dosage (16) 16
association (15) 15
internal medicine (15) 15
platelet aggregation - drug effects (15) 15
troponin t - blood (15) 15
biomarkers - blood (13) 13
blood platelets (13) 13
cardiology (13) 13
guidelines (13) 13
predictive value of tests (13) 13
diagnosis (12) 12
heart attack (12) 12
myocardial infarction - diagnosis (12) 12
prasugrel (12) 12
time factors (12) 12
aspirin (11) 11
cardiovascular disease (11) 11
intervention (11) 11
myocardial infarction - blood (11) 11
cardiac patients (10) 10
follow-up studies (10) 10
management (10) 10
platelets (10) 10
risk assessment (10) 10
roc curve (10) 10
studies (10) 10
antiplatelet therapy (9) 9
cardiology and cardiovascular medicine (9) 9
drug therapy (9) 9
early diagnosis (9) 9
inhibition (9) 9
medicine, general & internal (9) 9
myocardial infarction (9) 9
platelet function tests (9) 9
task-force (9) 9
troponin (9) 9
acute coronary syndrome (8) 8
blood platelets - drug effects (8) 8
coronary artery disease - blood (8) 8
dose-response relationship, drug (8) 8
electrocardiography (8) 8
european-society (8) 8
germany (8) 8
impact (8) 8
kaplan-meier estimate (8) 8
myocardial infarction - mortality (8) 8
platelet aggregation inhibitors - adverse effects (8) 8
acute myocardial-infarction (7) 7
adult (7) 7
aggregation (7) 7
angioplasty, balloon, coronary (7) 7
cardiovascular diseases (7) 7
care and treatment (7) 7
coronary angiography (7) 7
disease (7) 7
myocardial-infarction (7) 7
platelet activation - drug effects (7) 7
platelet aggregation inhibitors - therapeutic use (7) 7
prognostic value (7) 7
therapy (7) 7
ticlopidine - therapeutic use (7) 7
analysis (6) 6
coronary artery disease - therapy (6) 6
ischemia (6) 6
natriuretic peptide (6) 6
patients (6) 6
pharmacogenetics (6) 6
polymorphism (6) 6
research (6) 6
st-segment elevation (6) 6
ticlopidine - adverse effects (6) 6
ticlopidine - pharmacology (6) 6
acute disease (5) 5
angina pectoris (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2008, Volume 51, Issue 20, pp. 1925 - 1934
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 55, Issue 22, pp. 2427 - 2434
Objectives The aim of this study was to evaluate the relative impact of demographic and clinical variables versus the cytochrome P450 2C19 ( CYP2C19 )... 
Cardiovascular | Internal Medicine | polymorphism | predictor | antiplatelet therapy | CYP2C19 | platelet function | RESPONSIVENESS | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | REACTIVITY | DETERMINANT | ANTIPLATELET | THERAPY | INHIBITION | TYPE-2 DIABETES-MELLITUS | INTERVENTION | AGGREGATION | Multivariate Analysis | Predictive Value of Tests | Confidence Intervals | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Male | Dose-Response Relationship, Drug | Prosthesis Failure | Angioplasty, Balloon, Coronary - mortality | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - administration & dosage | Adult | Female | Platelet Aggregation - drug effects | Odds Ratio | Platelet Aggregation - genetics | Stents | Drug-Eluting Stents | Coronary Stenosis - therapy | Drug Administration Schedule | Risk Assessment | Angioplasty, Balloon, Coronary - methods | Probability | Coronary Stenosis - drug therapy | Logistic Models | Polymorphism, Genetic - drug effects | Ticlopidine - analogs & derivatives | Coronary Stenosis - genetics | Cytochrome P-450 CYP2C19 | Survival Analysis | Aged | Coronary Stenosis - mortality | Elective Surgical Procedures | Medical colleges | Genetic aspects | Stent (Surgery) | Cytochrome P-450 | Hypertension | Plasma | Aspirin | Heart attacks | Statistical methods | Thrombosis | Polymerase chain reaction | Confidence intervals | Variables | Body mass index | Blood platelets | Intubation | Clinical medicine | Diabetes | Drug therapy | Drug dosages | Deoxyribonucleic acid--DNA | Polymorphism
Journal Article
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 11/2011, Volume 306, Issue 20, pp. 2221 - 2228
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 3, pp. 286 - 293
Journal Article
Journal Article
Deutsche Medizinische Wochenschrift, ISSN 0012-0472, 06/2016, Volume 141, Issue 11, pp. 782 - 785
Journal Article
American Heart Journal, ISSN 0002-8703, 2011, Volume 162, Issue 3, pp. 518 - 526.e5
Background Pharmacodynamic studies reported an amplified on-clopidogrel platelet inhibition in smokers potentially caused by an increased metabolic drug... 
Cardiovascular | PERCUTANEOUS CORONARY INTERVENTION | CIGARETTE-SMOKING | CARDIAC & CARDIOVASCULAR SYSTEMS | INHIBITION | PLATELET-AGGREGATION | STENT THROMBOSIS | OF-FUNCTION POLYMORPHISM | REACTIVITY | EXTRINSIC FACTORS | ASSOCIATION | ACTIVE METABOLITE | Piperazines - administration & dosage | Smoking - adverse effects | Prasugrel Hydrochloride | Purinergic P2Y Receptor Antagonists - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Thiophenes - administration & dosage | Blood Platelets - physiology | Coronary Artery Disease - blood | Cytochrome P-450 CYP1A2 - blood | Dose-Response Relationship, Drug | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - administration & dosage | Female | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Piperazines - pharmacokinetics | Coronary Artery Disease - etiology | Smoking - blood | Risk Factors | Purinergic P2Y Receptor Antagonists - pharmacokinetics | Platelet Aggregation - physiology | Treatment Outcome | Coronary Artery Disease - drug therapy | Ticlopidine - analogs & derivatives | Cross-Over Studies | Thiophenes - pharmacokinetics | Aged | Hypertension | Enzymes | Heart attacks | Mortality | Statistical methods | Nitrates | Cigarettes | Studies | Variables | Body mass index | Blood platelets | Diabetes | Drug therapy | Acute coronary syndromes | Smoking | Logistics
Journal Article